Regenerative Medicine for Athletic Performance in West Valley City, UT

The numbers that actually change how you stock in West Valley City

If a sales sheet cannot tell you that West Valley City is JF (Noridian Healthcare Solutions) and that adult diabetes here is 10.6% (PLACES 2023), it is selling units, not a program. That is the regenerative medicine for athletes conversation we actually have.

The chart problems we still see in UT

• Adult arthritis here is 20.9% (CDC PLACES 2023, crude). That is the joint-pain backdrop for PRP and orthobiologics — not a promise that every arthritic knee is a candidate. 19.8% of adults 18–64 here currently lack health insurance (CDC PLACES ACCESS2, 2023). Cash-pay PRP and Medicare CTPs cannot share one consent script. PRP is autologous and not a 361 allograft, but “patient prefers regenerative” is still not medical necessity in Utah.
• PRP is autologous and not an HCT/P 361 allograft, but payers in JF still expect diagnosis-driven documentation. A 1-minute spin does not replace a medically necessary indication or a procedure note.
• Utah is outside CDC's historical Diabetes Belt core, but the national 12% diabetes figure still applies as a planning baseline until a clinic uses its own payer mix. Clinics asking for regenerative inventory still have to separate HCT/P 361 homologous-use products from unapproved “stem cell” claims (FDA 21 CFR 1271).

Why we will not invent a West Valley City diabetes rate

19.8% of adults 18–64 here currently lack health insurance (CDC PLACES ACCESS2, 2023). Cash-pay PRP and Medicare CTPs cannot share one consent script. A city under 250k with 140,230 residents will still mix those payers. CDC PLACES (2023, crude) estimates 10.6% of adults in West Valley City have diagnosed diabetes — 1.4 points below the U.S. 12% figure. Build two utilization policies if you do both cash PRP and Medicare CTPs.

Do this before you expand SKUs